The Current Ratio as of November 2024 (TTM) for Regencell Bioscience Holdings Limited (RGC) is 41.92

According to Regencell Bioscience Holdings Limited’s latest financial reports and current stock price. The company's current Current Ratio is 41.92. This represents a change of 174.57% compared to the average of 15.27 of the last 4 quarters.

Regencell Bioscience Holdings Limited (RGC) Historical Current Ratio (quarterly & annually)

How has RGC Current Ratio performed in the past?

The mean historical Current Ratio of Regencell Bioscience Holdings Limited over the last ten years is 9.30. The current 41.92 Current Ratio has changed 44.97% with respect to the historical average. Over the past ten years (40 quarters), RGC's Current Ratio was at its highest in in the December 2021 quarter at 13.94K. The Current Ratio was at its lowest in in the September 2019 quarter at 0.

Regencell Bioscience Holdings Limited (RGC) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Regencell Bioscience Holdings Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Regencell Bioscience Holdings Limited (RGC) Average Current Ratio

How has RGC Current Ratio performed in the past?

The current Current Ratio of Regencell Bioscience Holdings Limited (RGC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Regencell Bioscience Holdings Limited (RGC) Current Ratio vs. Peers

How is RGC’s Current Ratio compared to its peers?

Regencell Bioscience Holdings Limited’s Current Ratio is greater than Delta 9 Cannabis Inc. (0.30), less than RAMM Pharma Corp. (0), greater than City View Green Holdings Inc. (0.01), greater than Craftport Cannabis Corp. (0.03), greater than Speakeasy Cannabis Club Ltd. (1.40), greater than Procaps Group, S.A. (1.47), greater than Silver Spike Investment Corp. (6.09), greater than Eagle Pharmaceuticals, Inc. (1.70), greater than Phibro Animal Health Corporation (3.23), greater than Sunshine Biopharma, Inc. (5.74), greater than Cosmos Health Inc. (1.44), greater than AcelRx Pharmaceuticals, Inc. (4.04), greater than HEXO Corp. (0.81), greater than Prestige Consumer Healthcare Inc. (3.56), greater than Collegium Pharmaceutical, Inc. (0.97), greater than ANI Pharmaceuticals, Inc. (2.74), greater than Procaps Group S.A. (1.47),

Build a custom stock screener for Regencell Bioscience Holdings Limited (RGC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Regencell Bioscience Holdings Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Regencell Bioscience Holdings Limited (RGC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Regencell Bioscience Holdings Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.